LEXICON PHARMACEUTICALS, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $49.8 | $31.1 | $1.2 | $0.1 | $0.3 |
| Operating income | -$48.9 | -$197.1 | -$171.8 | -$100.8 | -$87.1 |
| Net income | -$50.3 | -$200.4 | -$177.1 | -$101.9 | -$87.8 |
| Balance Sheet | |||||
| Total debt | — | — | — | $48.6 | — |
| Cash Flow Statement | |||||
| Free cash flow | -$67.9 | -$179.8 | -$162.4 | -$90.2 | -$88.2 |
| Share repurchases | — | $1.7 | $0.8 | $0.9 | $2.7 |
Shares outstanding 445.0M · Free float 46.3%
Annual filing data through FY ended December 31, 2025; float as of September 25, 2026.